Straits Times Index
3,290.70 +24.75 (+0.76%) S&P 500
5,222.68 +8.60 (+0.16%) Dow
39,512.84 +125.08 (+0.32%) Nasdaq
16,340.87 -5.40 (-0.03%) Bitcoin USD
61,395.65 +285.63 (+0.47%) CMC Crypto 200
1,272.38 -85.63 (-6.30%)
Verona Pharma plc (VRNA)
After hours:
| Previous close | 14.75 |
| Open | 14.70 |
| Bid | 14.80 x 300 |
| Ask | 14.87 x 100 |
| Day's range | 14.70 - 15.11 |
| 52-week range | 11.83 - 23.07 |
| Volume | |
| Avg. volume | 454,496 |
| Market cap | 1.15B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview
Insights into Verona Pharma's First Quarter Performance and Future Prospects
- Insider Monkey
Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript
Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript May 9, 2024 Verona Pharma plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to Verona Pharma’s First Quarter 2024 Financial Results and Operating Highlights Conference Call. At […]
- Insider Monkey
Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript
Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript February 29, 2024 Verona Pharma plc beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23. VRNA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to Verona Pharma’s Fourth Quarter […]
